Literature DB >> 25308359

Role of general practitioners in prevention and treatment of hepatitis B in China.

Jing-Jing Ren1, Ying Liu, Wen Ren, Yan Qiu, Bing Wang, Ping Chen, Kai-Jin Xu, Shi-Gui Yang, Jun Yao, Lan-Juan Li.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) infection may impose an economic burden to patients or their families. The prevention and control of HBV could effectively reduce the burden. However, the management of HBV-related patients has not been well controlled in China. With the development of general practitioner (GP) system in this country, GPs may greatly improve the management of the patients with HBV infection. However, the role of GPs in controlling HBV infection has been rarely studied. DATA SOURCES: A literature search of PubMed, CNKI, Wanfang data and VIP was performed with the following key words: "general practitioner", "family physician", "community management", "community health care workers", "family practice", "hepatitis B virus", "HBV", "HBV vaccination", "HBV prevention", "HBV management", "HBV treatment", "antiviral therapy" and "chronic hepatitis B (CHB)". The information about the GPs-involved prevention, diagnosis and treatment of CHB was reviewed.
RESULTS: The reports on the role of GPs in the prevention, diagnosis and treatment of HBV infection are few. But the experiences from Western countries demonstrated that GPs could play a significant role in the management of patients with CHB. The importance of GPs is obvious although there are some difficulties in China. GPs and health officials at different levels should work together in the management of patients with CHB.
CONCLUSIONS: The involvement of GPs in the management of patients with HBV infection is effective in China. But GPs' knowledge and skills for the control of HBV infection have to be improved currently. GPs' involvement will enforce the management of CHB in China in the near future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25308359     DOI: 10.1016/s1499-3872(14)60313-1

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  4 in total

Review 1.  The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries.

Authors:  A Bechini; M Levi; A Falla; A Ahmad; I Veldhuijzen; E Tiscione; P Bonanni
Journal:  J Prev Med Hyg       Date:  2016

2.  Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.

Authors:  Yanli Liu; Sai Zhang; Yali Zhao; Juan Du; Guanghui Jin; Shuang Shao; Xiaoqin Lu
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

3.  An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation.

Authors:  Hao Li; Chunyu Sheng; Hongbo Liu; Guangze Liu; Xinying Du; Juan Du; Linsheng Zhan; Peng Li; Chaojie Yang; Lihua Qi; Jian Wang; Xiaoxia Yang; Leili Jia; Jing Xie; Ligui Wang; Rongzhang Hao; Dongping Xu; Yigang Tong; Yusen Zhou; Jianjun Zhou; Yansong Sun; Qiao Li; Shaofu Qiu; Hongbin Song
Journal:  Int J Biol Sci       Date:  2016-08-05       Impact factor: 6.580

4.  Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: A systematic analysis.

Authors:  Shu Chen; Lei Guo; Zhan Wang; Wenhui Mao; Yanfeng Ge; Xiaohua Ying; Jing Fang; Qian Long; Qin Liu; Hao Xiang; Chenkai Wu; Chaowei Fu; Di Dong; Jiahui Zhang; Ju Sun; Lichun Tian; Limin Wang; Maigeng Zhou; Mei Zhang; Mengcen Qian; Wei Liu; Weixi Jiang; Wenmeng Feng; Xinying Zeng; Xiyu Ding; Xun Lei; Rachel Tolhurst; Ling Xu; Haidong Wang; Faye Ziegeweid; Scott Glenn; John S Ji; Mary Story; Gavin Yamey; Shenglan Tang
Journal:  PLoS Med       Date:  2019-11-19       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.